In the UK, the National Institute for Health and Care Excellence (NICE) recommended the gene therapy for reimbursement by the National Health Service (NHS) via a...
In hereditary spastic paraplegia type 50 (SPG50)—an ultrarare form of neurodevelopmental/neurological disorder described as ideal for gene therapy—Canadian researchers successfully created and completed a phase 1...
Side view man with hearing issues Image by freepik Approximately 430 million people live with disabling hearing loss, and 26 million individuals are affected by congenital...
Artist rendition of genetically modifying adenoviruses Image by freepik Since their discovery in the 1950s, adenoviruses have been increasingly recognized as versatile and powerful gene therapy...